Unknown

Dataset Information

0

KV11.1, NaV1.5, and CaV1.2 Transporter Proteins as Antitarget for Drug Cardiotoxicity.

ABSTRACT: Safety assessment of pharmaceuticals is a rapidly developing area of pharmacy and medicine. The new advanced guidelines for testing the toxicity of compounds require specialized tools that provide information on the tested drug in a quick and reliable way. Ion channels represent the third-largest target. As mentioned in the literature, ion channels are an indispensable part of the heart's work. In this paper the most important information concerning the guidelines for cardiotoxicity testing and the way the tests are conducted has been collected. Attention has been focused on the role of selected ion channels in this process.

SUBMITTER: Kowalska M 

PROVIDER: S-EPMC7663169 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

K<sub>V</sub>11.1, Na<sub>V</sub>1.5, and Ca<sub>V</sub>1.2 Transporter Proteins as Antitarget for Drug Cardiotoxicity.

Kowalska Magdalena M   Nowaczyk Jacek J   Nowaczyk Alicja A  

International journal of molecular sciences 20201030 21

Safety assessment of pharmaceuticals is a rapidly developing area of pharmacy and medicine. The new advanced guidelines for testing the toxicity of compounds require specialized tools that provide information on the tested drug in a quick and reliable way. Ion channels represent the third-largest target. As mentioned in the literature, ion channels are an indispensable part of the heart's work. In this paper the most important information concerning the guidelines for cardiotoxicity testing and  ...[more]

Similar Datasets

Unknown Antiepileptic Drug Tiagabine Does Not Directly Target Key Cardiac Ion Channels Kv11.1, Nav1.5 and Cav1.2.
| S-EPMC8226520 | biostudies-literature
Unknown Tuning HERG out: antitarget QSAR models for drug development.
| S-EPMC4593700 | biostudies-literature
Unknown Transporter-mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target.
| S-EPMC3281213 | biostudies-literature
Unknown Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.
| S-EPMC4322540 | biostudies-literature
Unknown Diseases caused by mutations in Nav1.5 interacting proteins.
| S-EPMC4226528 | biostudies-literature
Unknown Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity.
| S-EPMC6489130 | biostudies-literature
Unknown Developmental control of CaV1.2 L-type calcium channel splicing by Fox proteins.
| S-EPMC2725710 | biostudies-literature
Unknown β-Adrenergic control of sarcolemmal CaV1.2 abundance by small GTPase Rab proteins.
| S-EPMC7896340 | biostudies-literature
Unknown Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity.
| S-EPMC7283551 | biostudies-literature
Unknown Kinetic model for NS1643 drug activation of WT and L529I variants of Kv11.1 (hERG1) potassium channel.
| S-EPMC4375712 | biostudies-literature